How fast does Paxlovid work?
Key Points
Most people who take one 5-day course of Paxlovid (nirmatrelvir and ritonavir) recover from COVID, although there is a possibility of COVID rebound. Currently there are no reports of severe outcomes related to COVID rebound.
Paxlovid continues to be recommended for early-stage treatment (within 5 days of symptoms onset) of mild to moderate COVID-19 in people at high risk for severe disease. It can lessen symptoms and prevent hospitalization and death. Paxlovid reduces the risk of being hospitalized by 88% when taken within 5 days of symptom onset.
Do I have to isolate myself after I finish Paxlovid?
Whether you have taken Paxlovid or not, you can end home isolation after a full 5 days if:
If you test positive again after just finishing Paxlovid you should restart the 5-day isolation period and contact your healthcare provider for further instructions.
Most doctors do not prescribe a second round of Paxlovid for rebound. It is indicated only for a 5 day treatment in product labeling. Case reports suggest that people who develop COVID rebound after completing Paxlovid have either no symptoms or mild illness. Currently there have been no reports of severe outcomes related to COVID rebound.
This is not all the information you need to know about Paxlovid (nirmatrelvir and ritonavir) for safe and effective use and does not take the place of your doctor’s directions. Review the full Paxlovid product information and discuss this information and any questions you have with your doctor or other health care provider.
Related medical questions
- How fast does Paxlovid work?
- Paxlovid side effects: 8 key things to know
- Can you take Paxlovid twice if COVID rebounds?
- Paxlovid side effects: 8 key things to know
- How fast does Paxlovid work?
- Can you take Paxlovid twice if COVID rebounds?
- Does Paxlovid prevent Long COVID?
- How effective is Paxlovid for COVID-19?
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions